59 phenotypes from 5 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ireb2tm1.1Eal/Ireb2tm1.1Eal B6J.129-Ireb2tm1.1Eal	abnormal axon morphology	J:217335
	abnormal cerebellum white matter morphology	J:217335
	abnormal cerebral cortex morphology	J:217335
	abnormal corpus callosum morphology	J:217335
	abnormal dorsal striatum morphology	J:217335
	abnormal hippocampal pyramidal neuron dendrite morphology	J:217335
	abnormal hippocampus pyramidal cell morphology	J:217335
	abnormal iron homeostasis	J:217335
	abnormal iron level	J:217335
	abnormal oligodendrocyte morphology	J:217335
	abnormal Purkinje cell morphology	J:217335
	abnormal superior colliculus morphology	J:217335
	abnormal thalamus morphology	J:217335
	normal behavior/neurological phenotype	J:217335
	decreased brain iron level	J:217335
	decreased heart iron level	J:217335
	decreased hematocrit	J:217335
	decreased hemoglobin content	J:217335
	decreased locomotor activity	J:217335
	decreased mean corpuscular hemoglobin	J:217335
	decreased mean corpuscular hemoglobin concentration	J:217335
	decreased mean corpuscular volume	J:217335
	decreased mean platelet volume	J:217335
	decreased vertical activity	J:217335
	impaired coordination	J:217335
	increased brain iron level	J:217335
	increased circulating ferritin level	J:217335
	increased intestinal iron level	J:217335
	increased kidney iron level	J:217335
	increased liver iron level	J:217335
	increased porphyrin level	J:217335
	increased red blood cell distribution width	J:217335
	increased thermal nociceptive threshold	J:217335
	microcytic anemia	J:217335
	normal nervous system phenotype	J:217335
	porphyria	J:217335
	normal skeleton phenotype	J:217335
	thrombocytopenia	J:217335
Ireb2tm1.1Mwh/Ireb2tm1.1Mwh involves: 129P2/OlaHsd * C57BL/6 * SJL	no abnormal phenotype detected	J:103414
Ireb2tm1.2Mwh/Ireb2tm1.2Mwh involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL	abnormal duodenum morphology	J:103414
	abnormal erythrocyte morphology	J:103414
	abnormal iron homeostasis	J:103414
	abnormal locomotor behavior	J:103414
	decreased erythrocyte cell number	J:103414
	decreased hematocrit	J:103414
	decreased hemoglobin content	J:103414
	decreased spleen iron level	J:103414
	increased intestinal iron level	J:103414
	increased liver iron level	J:103414
	microcytosis	J:103414
Ireb2tm1Mwh/Ireb2tm1Mwh involves: 129P2/OlaHsd * C57BL/6J	abnormal erythrocyte morphology	J:105124
	abnormal iron homeostasis	J:105124
	abnormal locomotor behavior	J:103414
	normal behavior/neurological phenotype	J:105124
	decreased hematocrit	J:105124
	decreased hemoglobin content	J:105124
	decreased mean corpuscular volume	J:105124
	decreased spleen iron level	J:105124
	increased intestinal iron level	J:105124
	increased liver iron level	J:105124
	microcytosis	J:105124
Ireb2tm1Roua/Ireb2tm1Roua B6.Cg-Ireb2tm1Roua	decreased hematocrit	J:176655
	decreased hemoglobin content	J:176655
	decreased mean corpuscular hemoglobin	J:176655
	decreased mean corpuscular hemoglobin concentration	J:176655
	decreased mean corpuscular volume	J:176655
	decreased spleen iron level	J:176655
	increased liver iron level	J:176655
	microcytosis	J:176655
Ireb2tm1Roua/Ireb2tm1Roua involves: C57BL/6	abnormal cerebellum morphology	J:67313
	abnormal corpora quadrigemina morphology	J:67313
	abnormal gait	J:67313
	abnormal iron homeostasis	J:87889
	abnormal locomotor behavior	J:67313
	abnormal posture	J:67313
	abnormal thalamus morphology	J:67313
	abnormal vestibular system physiology	J:67313
	ataxia	J:67313
	bradykinesia	J:67313
	decreased grip strength	J:67313
	decreased Purkinje cell number	J:67313
	impaired balance	J:67313
	increased brain iron level	J:67313
	increased circulating ferritin level	J:67313
	increased intestinal iron level	J:67313
	increased liver iron level	J:67313
	kyphosis	J:67313
	normal liver/biliary system phenotype	J:67313
	Purkinje cell degeneration	J:67313
	tremors	J:67313